|
1
|
Yamaguchi T and Sugimoto T: Bone
metabolism and fracture risk in type 2 diabetes mellitus. Endocr J.
58:613–624. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Forsén L, Meyer HE, Midthjell K and Edna
TH: Diabetes mellitus and the incidence of hip fracture: results
from the Nord-Trøndelag Health Survey. Diabetologia. 42:920–925.
1999.PubMed/NCBI
|
|
3
|
Retzepi M and Donos N: The effect of
diabetes mellitus on osseous healing. Clin Oral Implants Res.
21:673–681. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lecka-Czernik B: Bone loss in diabetes:
use of antidiabetic thiazolidinediones and secondary osteoporosis.
Curr Osteoporos Rep. 8:178–184. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Horcajada-Molteni MN, Chanteranne B,
Lebecque P, Davicco MJ, Coxam V, Young A and Barlet JP: Amylin and
bone metabolism in streptozotocin-induced diabetic rats. J Bone
Miner Res. 16:958–965. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Suzuki K, Sugimoto C, Takizawa M, Ishizuka
S, Kikuyama M, Togawa H, Taguchi Y, Nosaka K, Seino Y and Ishida H:
Correlations between bone mineral density and circulating bone
metabolic markers in diabetic patients. Diabetes Res Clin Pract.
48:185–191. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wakasugi M, Wakao R, Tawata M, Gan N,
Koizumi K and Onaya T: Bone mineral density measured by dual energy
x-ray absorptiometry in patients with non-insulin-dependent
diabetes mellitus. Bone. 14:29–33. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Barrett-Connor E and Holbrook TL: Sex
differences in osteoporosis in older adults with
non-insulin-dependent diabetes mellitus. JAMA. 268:3333–3337. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hamann C, Goettsch C, Mettelsiefen J,
Henkenjohann V, Rauner M, Hempel U, Bernhardt R, Fratzl-Zelman N,
Roschger P, Rammelt S, Günther KP and Hofbauer LC: Delayed bone
regeneration and low bone mass in a rat model of insulin-resistant
type 2 diabetes mellitus is due to impaired osteoblast function. Am
J Physiol Endocrinol Metab. 301:E1220–E1228. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Strotmeyer ES, Cauley JA, Schwartz AV,
Nevitt MC, Resnick HE, Bauer DC, Tylavsky FA, et al: Nontraumatic
fracture risk with diabetes mellitus and impaired fasting glucose
in older white and black adults: the health, aging, and body
composition study. Arch Intern Med. 165:1612–1617. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bonds DE, Larson JC, Schwartz AV,
Strotmeyer ES, Robbins J, Rodriguez BL, Johnson KC and Margolis KL:
Risk of fracture in women with type 2 diabetes: the Women’s Health
Initiative Observational Study. J Clin Endocrinol Metab.
91:3404–3410. 2006.
|
|
12
|
Zhou Y, Li Y, Zhang D, Wang J and Yang H:
Prevalence and predictors of osteopenia and osteoporosis in
postmenopausal Chinese women with type 2 diabetes. Diabetes Res
Clin Pract. 90:261–269. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kanazawa I, Yamaguchi T, Yamamoto M,
Yamauchi M, Yano S and Sugimoto T: Serum osteocalcin/bone-specific
alkaline phosphatase ratio is a predictor for the presence of
vertebral fractures in men with type 2 diabetes. Calcif Tissue Int.
85:228–234. 2009. View Article : Google Scholar
|
|
14
|
Takizawa M, Suzuki K, Matsubayashi T,
Kikuyama M, Suzuki H, Takahashi K, Katsuta H, Mitsuhashi J, Nishida
S, Yamaguchi S, Yoshimoto K, Itagaki E and Ishida H: Increased bone
resorption may play a crucial role in the occurrence of osteopenia
in patients with type 2 diabetes: Possible involvement of
accelerated polyol pathway in its pathogenesis. Diabetes Res Clin
Pract. 82:119–126. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Okazaki R, Miura M, Toriumi M, Taguchi M,
Hirota Y, Fukumoto S, Fujita T, Tanaka K and Takeuchi A: Short-term
treatment with troglitazone decreases bone turnover in patients
with type 2 diabetes mellitus. Endocr J. 46:795–801. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fujii H, Hamada Y and Fukagawa M: Bone
formation in spontaneously diabetic Torii-newly established model
of non-obese type 2 diabetes rats. Bone. 42:372–379. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kawashima Y, Chen J, Sun H, Lann D, Hajjar
RJ, Yakar S and Leroith D: Apolipoprotein E deficiency abrogates
insulin resistance in a mouse model of type 2 diabetes mellitus.
Diabetologia. 52:1434–1441. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang S, Kaw M, Harris MT, Ebraheim N,
McInerney MF, Najjar SM and Lecka-Czernik B: Decreased
osteoclastogenesis and high bone mass in mice with impaired insulin
clearance due to liver-specific inactivation to CEACAM1. Bone.
46:1138–1145. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dienelt A and zur Nieden NI: Hyperglycemia
impairs skeletogenesis from embryonic stem cells by affecting
osteoblast and osteoclast differentiation. Stem Cells Dev.
20:465–474. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Elbaz A, Wu X, Rivas D, Gimble JM and
Duque G: Inhibition of fatty acid biosynthesis prevents adipocyte
lipotoxicity on human osteoblasts in vitro. J Cell Mol Med.
14:982–991. 2010. View Article : Google Scholar : PubMed/NCBI
|
